Please provide your email address to receive an email when new articles are posted on . Sublingual immunotherapy for house dust mites improved allergic rhinitis symptoms over a 1-year period among ...

Please provide your email address to receive an email when new articles are posted on . Researchers called this the first study among children aged 1 to 4 years. The treatment group saw improved ...

December 13, 2010 (Dubai, United Arab Emirates) — Four years of sublingual immunotherapy (SLIT) was found to confer benefits that were maintained for 8 years post-SLIT, and response to retreatment at ...

Findings showed Staloral Birch, compared with placebo, demonstrated a 41% improvement in the ARC total combined score during the second pollen season. Topline data were announced from a phase 3b trial ...

Subcutaneous allergen-specific immunotherapy has long been used in allergic rhinitis and/or asthma and has been recognized to be efficacious. However, owing to the inconvenience of injection and the ...

BAAR, Switzerland--(BUSINESS WIRE)--Stallergenes Greer, a global leader in allergy therapeutics, will present positive results from its SPEED survey at the upcoming CFA congress (Congrès Francophone d ...

Medically reviewed by Corinne Savides Happel, MD Key Takeaways Allergy immunotherapy works by gradually exposing the immune system to allergens to reduce sensitivity.Allergy shots have a build-up ...

- ODACTRA is now indicated to treat house dust mite (HDM)-induced allergic rhinitis, with or without conjunctivitis, in children ages 5 through 11 years, in addition to patients 12 through 65 years of ...

DelveInsight's House Dust Mite Disease Market Insights report includes a comprehensive understanding of current treatment practices, house dust mite disease emerging drugs, market share of individual ...